ARP

RSAC 2024: Genians NAC-Driven ZTNA Leads Zero Trust Security Journeys

Retrieved on: 
Wednesday, May 1, 2024
Data Management, Security, IOT (Internet of Things), Technology, Software, Networks, Cloud, HIPAA, ARP, RADIUS, GDPR, Internet of things, SME, NAC, SWG, Active Directory, RSA Conference, TCP, OT, Conference, Internet, PCI, Secure, SNMP, Automation, MFA, Acquisition, ZTNA, Virtual private network, FIDO2, VPN, Network Access Control, NIST, RSAC, WLAN, Cloud Control, BYOD, Video game

Genians, a pioneer in Zero Trust Network Access (ZTNA) powered by industry-leading Network Access Control (NAC) solutions, will showcase its latest advancements at the RSA Conference in San Francisco, May 6-9 (Booth #342, South Expo).

Key Points: 
  • Genians, a pioneer in Zero Trust Network Access (ZTNA) powered by industry-leading Network Access Control (NAC) solutions, will showcase its latest advancements at the RSA Conference in San Francisco, May 6-9 (Booth #342, South Expo).
  • Recognizing the growing need for secure remote access and cloud security, Genians expanded its offerings to include ZTNA solutions.
  • At RSAC 2024, Genians will present live demos covering the following topics:
    Unparalleled Network Visibility: Gain real-time insights with Genians' Layer 2-based Network Sensing and Device Platform Intelligence for unmatched network observability.
  • Consolidated Security Control: Gain comprehensive access control over IP/MAC addresses, switch ports, and WLAN security with a centralized management platform.

Rigaku Analytical Devices Awarded Funding for Year 3 of its R&D Contract from the TSA to Enhance Raman Technology for Screening

Retrieved on: 
Monday, April 1, 2024
Technology, Manufacturing, Other Transport, Air, Transport, Security, Other Manufacturing, Other Defense, Defense, Hardware, Chemicals, Plastics, Narcotic, Conventional weapon, Law enforcement, Aviation, Airport, TSA, ARP, Raman, Rigaku, Risk management

Rigaku was originally awarded a firm fixed-price contract in September of 2021, having a one-year base period of performance with two option years for a total funding opportunity of $1.6 million.

Key Points: 
  • Rigaku was originally awarded a firm fixed-price contract in September of 2021, having a one-year base period of performance with two option years for a total funding opportunity of $1.6 million.
  • The TSA Alarm Resolution Program was formed in 2018 when the TSA identified capability gaps in primary screening procedures and the need to evaluate next-generation solutions.
  • By utilizing 1064 nm Raman technology, Rigaku CQL analyzers have the ability to analyze dirty, colored or mixed materials – even through translucent packaging – without fluorescence interference.
  • “The extension of this contract into its third year allows the Rigaku Raman technology continued field data collections to enhance and test the technology,” said Mathew Lynch, President of Rigaku Analytical Devices.

ICP DAS-BMP Secures Pivotal TPU Deals with Medical Materials Leaders in U.S. and Japan, Boosts Product Reliability

Retrieved on: 
Tuesday, March 19, 2024
DAS, Hardness, Plasticizer, ARC, ESG, PICC, Barium sulfate, ICP, ALP, ALC, Research, Volatile organic compound, ARP, Plastic, TPU, Medical device

ICP DAS-BMP, Asia's first medical-grade TPU supplier, produces three main series of products: Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series).

Key Points: 
  • ICP DAS-BMP, Asia's first medical-grade TPU supplier, produces three main series of products: Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series).
  • All the TPU series are available in different hardness levels, colors, and concentrations of radiopaque fillers (Tungsten/Barium Sulfate).
  • These materials are widely utilized in manufacturing cardiovascular, urological, and gastrointestinal devices, as well as medical and electromedical consumables.
  • ICP DAS-BMP aims to offer safer, stable, and eco-friendly medical-grade TPU, collaborating with global medical device manufacturers to create long-term benefits and value.

ICP DAS-BMP Secures Pivotal TPU Deals with Medical Materials Leaders in U.S. and Japan, Boosts Product Reliability

Retrieved on: 
Tuesday, March 19, 2024
DAS, Hardness, Plasticizer, ARC, ESG, PICC, Barium sulfate, ICP, ALP, ALC, Research, Volatile organic compound, ARP, Plastic, TPU, Medical device

ICP DAS-BMP, Asia's first medical-grade TPU supplier, produces three main series of products: Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series).

Key Points: 
  • ICP DAS-BMP, Asia's first medical-grade TPU supplier, produces three main series of products: Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series).
  • All the TPU series are available in different hardness levels, colors, and concentrations of radiopaque fillers (Tungsten/Barium Sulfate).
  • These materials are widely utilized in manufacturing cardiovascular, urological, and gastrointestinal devices, as well as medical and electromedical consumables.
  • ICP DAS-BMP aims to offer safer, stable, and eco-friendly medical-grade TPU, collaborating with global medical device manufacturers to create long-term benefits and value.

Taro Expands Branded Over-the-Counter Portfolio in U.S. with the Launch of FeverAll® Liquid Oral Acetaminophen for Children Ages 2-11

Retrieved on: 
Wednesday, March 6, 2024
OTC, Pain, Fever, ARP, Amazon, Child, Parent, Fluid ounce, Ageing, Vaccine

HAWTHORNE, N.Y., March 6, 2024 /PRNewswire-PRWeb/ -- Taro Pharmaceuticals U.S.A., Inc., a subsidiary of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), today announced the expansion of its growing FeverAll® children's fever brand with a new liquid oral acetaminophen suspension format. New FeverAll® Children's Liquid Oral Acetaminophen, available in cherry and grape flavors, complements the brand's current offerings, which include three dosing levels of the doctor-recommended FeverAll® Acetaminophen Suppositories. The new liquid, which comes with a child-designed 15ml dosing cup, offers parents an additional option for the temporary relief of pain and fever in children aged two to 11, while the popular 80 mg suppository can be utilized in children as young as six months' of age.

Key Points: 
  • New oral liquid format expands the FeverAll® family of products, giving parents more options from the doctor-recommended suppository brand.
  • HAWTHORNE, N.Y., March 6, 2024 /PRNewswire-PRWeb/ -- Taro Pharmaceuticals U.S.A., Inc., a subsidiary of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), today announced the expansion of its growing FeverAll® children's fever brand with a new liquid oral acetaminophen suspension format.
  • New FeverAll® Children's Liquid Oral Acetaminophen, available in cherry and grape flavors, complements the brand's current offerings, which include three dosing levels of the doctor-recommended FeverAll® Acetaminophen Suppositories.
  • FeverAll® Liquid Oral Acetaminophen will launch on Amazon and will expand to other retailers in time for the cold and flu season.

Extensive R&D Capabilities：ICP DAS - BMP to Showcase a Broad Range of Medical-Grade TPU at MD&M West 2024, U.S.

Retrieved on: 
Tuesday, January 23, 2024
DAS, ICP, ALP, Hardness, Polymerization, BMP, Barium sulfate, Medicine, Next, TPU, ALC, Hall, Tungsten, ARP

HSINCHU, Jan. 22, 2024 /PRNewswire/ -- ICP DAS – BMP, Asia's first medical-grade thermoplastic polyurethane (TPU) supplier, will make its MD&M West debut in the United States.

Key Points: 
  • HSINCHU, Jan. 22, 2024 /PRNewswire/ -- ICP DAS – BMP, Asia's first medical-grade thermoplastic polyurethane (TPU) supplier, will make its MD&M West debut in the United States.
  • Kicking off 2024, the company presents a comprehensive range of top-quality medical-grade TPU series to the foremost experts and a thousand suppliers in the medical industry.
  • Next, ICP DAS – BMP will launch EARP and EALP series exhibiting high hardness, excellent heat resistance, and superior processability.
  • @MD&M West 2024, explore more with ICP DAS – BMP at booth 947 (Hall E) in the Anaheim Convention Center from February 6 to 8.

Extensive R&D Capabilities：ICP DAS - BMP to Showcase a Broad Range of Medical-Grade TPU at MD&M West 2024, U.S.

Retrieved on: 
Tuesday, January 23, 2024
DAS, ICP, ALP, Hardness, Polymerization, BMP, Barium sulfate, Medicine, Next, TPU, ALC, Hall, Tungsten, ARP

HSINCHU, Jan. 23, 2024 /PRNewswire/ -- ICP DAS – BMP, Asia's first medical-grade thermoplastic polyurethane (TPU) supplier, will make its MD&M West debut in the United States.

Key Points: 
  • HSINCHU, Jan. 23, 2024 /PRNewswire/ -- ICP DAS – BMP, Asia's first medical-grade thermoplastic polyurethane (TPU) supplier, will make its MD&M West debut in the United States.
  • Kicking off 2024, the company presents a comprehensive range of top-quality medical-grade TPU series to the foremost experts and a thousand suppliers in the medical industry.
  • Next, ICP DAS – BMP will launch EARP and EALP series exhibiting high hardness, excellent heat resistance, and superior processability.
  • @MD&M West 2024, explore more with ICP DAS – BMP at booth 947 (Hall E) in the Anaheim Convention Center from February 6 to 8.

BPAS Partners with the SS&C Automatic Rollover Program to Enhance Retirement Plan Servicing

Retrieved on: 
Monday, December 18, 2023
IRA, BPAS, ARP, Retirement, SS&C Technologies, SS&C

SYRACUSE, N.Y., Dec. 18, 2023 /PRNewswire/ -- BPAS, a leading provider of retirement and benefits administration services, is pleased to announce its AutoRollovers service has joined with SS&C Technologies' Automatic Rollover Program (ARP).

Key Points: 
  • SYRACUSE, N.Y., Dec. 18, 2023 /PRNewswire/ -- BPAS, a leading provider of retirement and benefits administration services, is pleased to announce its AutoRollovers service has joined with SS&C Technologies' Automatic Rollover Program (ARP).
  • SS&C's pioneering platform is designed to revolutionize the servicing needs of Third-Party Administrators (TPAs), recordkeepers, advisory firms, and plan sponsors.
  • BPAS AutoRollovers provides a hassle-free IRA solution designed for terminated participants facing mandatory distributions from their retirement accounts.
  • The collaboration between BPAS AutoRollovers and SS&C's ARP aims to simplify and streamline the administration of mandatory rollovers at the plan level, providing an efficient and user-friendly solution.

Northwell Health Pediatric Rheumatologist Recognized for Lifetime Achievement by the American College of Rheumatology

Retrieved on: 
Tuesday, November 14, 2023
Children, Biotechnology, Other Consumer, Other Health, Health, General Health, Other Science, Research, Consumer, Science, Teens, Interest group, CCMC, Hope, Pediatrics, Patient, Multimedia, Lupus, American College of Rheumatology, Arthritis, American College, Northwell Health, Rheumatology, Medical research, Dermatomyositis, Mentorship, Credit, MBA, MD, Eberhard, ACR, ARP, Vasculitis, Nursing, Child

For her dedication to research and leadership in rheumatology, Northwell Health’s Cohen Children’s Medical Center (CCMC) pediatric rheumatologist and Feinstein Institutes for Medical Research scientist Barbara Anne Eberhard, MD , has been awarded top honors by the American College of Rheumatology (ACR) and the Association of Rheumatology Professionals (ARP).

Key Points: 
  • For her dedication to research and leadership in rheumatology, Northwell Health’s Cohen Children’s Medical Center (CCMC) pediatric rheumatologist and Feinstein Institutes for Medical Research scientist Barbara Anne Eberhard, MD , has been awarded top honors by the American College of Rheumatology (ACR) and the Association of Rheumatology Professionals (ARP).
  • Dr. Eberhard was recognized, and named an “ACR Master,” during the ACR Convergence 2023 annual conference which is being held November 10-15 in San Diego, California.
  • View the full release here: https://www.businesswire.com/news/home/20231114668794/en/
    Dr. Barbara Anne Eberhard was recognized for lifetime achievement by the American College of Rheumatology.
  • (Credit: Feinstein Institutes)
    The ACR Master recognition is awarded to physician-researchers who have made significant contributions to the field of rheumatology.

Frederick Arts Council Publishes Magazine Featuring Artwork by Recipients of the C.A.N. Recover Grant Program

Retrieved on: 
Wednesday, November 15, 2023
Organization, LAA, Activate, NEA, ARP, Optimism, Pharmaceutical industry, Management, Coronavirus

FREDERICK, Md., Nov. 15, 2023 /PRNewswire-PRWeb/ -- The Frederick Arts Council released a magazine featuring the artwork of dozens of artists and arts organizations as a result of receiving funding that was made possible by a National Endowment for the Arts (NEA) American Rescue Plan (ARP) Grant to Local Arts Agencies (LAA) awarded in the amount of $500,000 to the Frederick Arts Council for sub-granting.

Key Points: 
  • FREDERICK, Md., Nov. 15, 2023 /PRNewswire-PRWeb/ -- The Frederick Arts Council released a magazine featuring the artwork of dozens of artists and arts organizations as a result of receiving funding that was made possible by a National Endowment for the Arts (NEA) American Rescue Plan (ARP) Grant to Local Arts Agencies (LAA) awarded in the amount of $500,000 to the Frederick Arts Council for sub-granting.
  • The Frederick Arts Council awarded a record number of grants and stipends to arts organizations and individual artists last year.
  • "We are excited to document some of the wonderfully creative artwork that resulted from this unique influx of support for the arts in Frederick," said Louise Kennelly, Executive Director of the Frederick Arts Council.
  • The magazine can also be found on the Frederick Arts Council's website.